Ϫ from hyperpolarized cells occurs via the conversion of CO2 to HCO 3 Ϫ and is reduced by ϳ50% with acetazolamide. A gap between the base equivalent current and short-circuit current was observed in all experiments and was traced to secretion of H ϩ via a ouabain-sensitive, K ϩ -dependent process (possibly H ϩ -K ϩ -ATPase), which partially neutralized the secreted HCO 3
Ϫ secretion predominating for forskolin stimulation and Cl Ϫ secretion predominating for stimuli that open basolateral K ϩ channels to hyperpolarize the cells. We used pH stat and ion substitution experiments to clarify the mechanisms and consequences of these two modes of secretion. We confirm that Calu-3 cells secrete primarily HCO 3 Ϫ in response to forskolin. Unexpectedly, HCO 3 Ϫ secretion continued in response to K ϩ channel openers, with Cl Ϫ secretion being added to it. Secretion of HCO 3 Ϫ from hyperpolarized cells occurs via the conversion of CO2 to HCO 3 Ϫ and is reduced by ϳ50% with acetazolamide. A gap between the base equivalent current and short-circuit current was observed in all experiments and was traced to secretion of H ϩ via a ouabain-sensitive, K ϩ -dependent process (possibly H ϩ -K ϩ -ATPase), which partially neutralized the secreted HCO 3 Ϫ . The conjoint secretion of HCO 3 Ϫ and H ϩ may help explain the puzzling finding that mucus secreted from normal and CF glands has the same acidic pH as does mucus from glands stimulated with forskolin or ACh. It may also help explain how human airway glands produce mucus that is hypotonic. mucus clearance; carbonic anhydrase; thapsigargin; 1-ethyl-2-benzimidazolinone SUBMUCOSAL GLANDS ARE the primary source of airway mucus, a rich mixture of water, salts, mucins, and the "anti-" compounds: antimicrobials, antiproteases, and antioxidants. Airway mucus helps maintain sterility of the lungs, but in cystic fibrosis (CF) , that function is severely compromised. CF results from loss-of-function mutations in CFTR, the gene for the cystic fibrosis transmembrane conductance regulator (CFTR), an ion channel that conducts Cl Ϫ and HCO 3
Ϫ
. CFTR also influences the operations of many other proteins.
CFTR is expressed in gland serous cells (10) , and its importance is demonstrated by the complete absence of vasoactive intestinal peptide (VIP)-or forskolin-mediated gland secretion in CF airways (17) . The serous cell malfunction hypothesis proposes that CFTR-dependent Cl Ϫ and HCO 3 Ϫ secretion normally drives water movement across the serous cells of the gland, but in CF the loss of functional CFTR causes initial secretions to be underhydrated and lower in pH. We hypothesized that the resulting mucus is thicker and that there is reduced bioavailability of serous cell antimicrobials. Hence airway innate defenses, which depend on both mucus clearance and a chemical shield, are rendered inadequate (36) . Tests of this hypothesis have been hampered by difficulties in studying the molecular mechanisms of gland secretion in situ.
The Calu-3 cell line was introduced as a serous cell model based on evidence that it expressed the same range of proteins as natural serous cells, including CFTR (11) , and formed functional, polarized monolayers that secreted anions in response to elevations of intracellular cAMP concentration ([cAMP] i ) and intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) (32) . Calu-3 cells have since been studied extensively, and a great deal is now known about how they function.
A comprehensive model of Calu-3 anion secretion ( Ϫ -mediated secretion, whereas elevation of [Ca 2ϩ ] i [or direct activation of K ϩ channels with 1-ethyl-2-benzimidazolinone (1-EBIO)] produces only Cl Ϫ -mediated secretion. This model (hereafter termed model 1) leads to several predictions about secretions from Calu-3 cells and, by extension, from airway glands. Model 1 predicts that CF gland secretions should be more acidic than normal, and gland mucus produced by elevations of [Ca 2ϩ ] i should be much more acidic than mucus produced by elevation of [cAMP] i . However, the pH of pig gland mucus is ϳ7.0 when stimulated via [Ca 2ϩ ] i -elevating (acetylcholine, ACh) or [cAMP] i -elevating (VIP/forskolin) pathways (18) , and pH is also ϳ7.0 in mucus from ACh-stimulated glands of either CF or normal human subjects (16) . To explain these results, it has been hypothesized that secondary processes in the gland modify secretions homeostatically as they pass from the serous acini along the mucous tubules and ducts, so that the pH of the final secretion is adjusted to near pH 7 regardless of the starting secretion (36) .
What about the initial serous cell secretions? Here, our results agree with the model qualitatively, but not quantitatively. During preliminary tests of the pH of Calu-3 secretions produced by different stimuli (Krouse ME, unpublished observations), we did not see the extreme pH values expected by a switch between 150 and 0 mM HCO 3 Ϫ concentrations as predicted by model 1 (Fig. 1, Ref. 8) . Also, Lee et al. (20) used isotopic flux measurements to determine that elevation of [Ca 2ϩ ] i in Calu-3 cells resulted in no increased Na ϩ absorption, whereas Cl Ϫ secretion accounted for only a portion of the short-circuit current (I SC ), and attributed the remaining component to HCO 3 Ϫ secretion (20) . That interpretation is consistent with the effect of bumetanide, which spares a large component of thapsigargin-stimulated I SC (20, 26) . To investigate these discrepancies, we have reinvestigated Calu-3 secretion using pH stat methods to determine whether additional mechanisms might account for our observations.
The results of these studies have led us to a modified (and more complex) model of Calu-3 secretion. In contrast to model 1, we found that HCO 3 Ϫ is secreted during elevation of [Ca 2ϩ ] i or in the presence of the direct K ϩ channel activator 1-EBIO despite decreased driving force on the Na ϩ -HCO 3 Ϫ (NBC) cotransporter. We provide evidence that HCO 3 Ϫ is accumulated above its electrochemical equilibrium by carbonic anhydrasecatalyzed conversion of CO 2 and H 2 O. More surprisingly, the expected alkalinization of the apical fluid during stimulation with 1-EBIO is partly masked by increased secretion of H ϩ , which we trace to the activity of an apical process that is inhibited by apical ouabain and by removal of apical K ϩ , suggesting an H ϩ -K ϩ -ATPase. Our evidence supports prior evidence that both HCO 3 Ϫ and Cl Ϫ secretion occur through the same apical conductance: CFTR.
METHODS
We studied Calu-3 monolayers in Ussing chambers using two paradigms. Short-circuit (I SC) experiments, where the transcellular voltage is clamped to zero, have the advantage of maximizing anion transport. To obtain a separate measure of base (HCO 3 Ϫ ) secretion, we also used the pH stat method in conjunction with ISC measurements.
Solutions
The standard solution was Krebs-Henseleit (K-H) solution, which contains (in mM): NaCl, 128; KCl, 4.6; CaCl 2, 2.5; MgSO4, 1.2; KH2PO4, 1.2; NaHCO3, 25; and glucose, 11.2. The K-H solution contains both Cl Ϫ and HCO 3 Ϫ anions. In Cl Ϫ -free solution, NaCl was replaced with Na-isethionate, all other Cl Ϫ salts were replaced with nitrate salts, and 3 M KCl bridges were replaced by 1 M Naisethionate bridges. For HCO 3 Ϫ -free solution, NaHCO3 was replaced with Na-HEPES and bubbled with O2. For standard pH stat experiments, the apical solution was as follows (in mM): NaCl, 150; KCl, 5; CaCl 2, 2.5; and MgSO4,1.2. For pH stat experiments with K ϩ -free apical solutions, the K ϩ salts were replaced with Na ϩ salts, and 1 M NaCl was replaced with 3 M KCl in the agar bridges. All solutions were made up at 80% volume, and distilled water was added until the osmolarity was 320 mosM, as measured on a vapor pressure osmometer (Wescor 5500; Wescor, Logan, UT). The pH of each solution was adjusted to be 7.4 at 37°C when bubbled with the appropriate gas.
Cell Culture
Monolayers of Calu-3 cells were grown on human placental collagen (HPC; Sigma, St. Louis, MO)-coated Snapwell inserts (1.13-cm 2 area) for 4 wk (28 Ϯ 12 days). The cells were fed from the basolateral side only and grown with an air interface.
I SC and pH Stat
The inserts were mounted in an Ussing chamber (12-ml volume apical and basolateral chamber), the voltage was short circuited with a Physiologic Instrument (San Diego, CA) VCC600, and the current was recorded on a Macintosh computer using MacLab. HCO 3 Ϫ -containing solutions were bubbled with 95% O2-5% CO2, and no-HCO 3 Ϫ and pH stat solutions were bubbled with 100% O2. The Ussing chambers were kept at 37°C with a temperature-controlled circulator (VWR Scientific, West Chester, PA). The voltage offset/junction potential and fluid resistance were measured and subtracted electronically before each experiment. Snapwells were mounted and allowed to reach a steady state (ϳ30 min) before the experiment was begun. A voltage pulse was passed across the monolayer every 20 s to measure monolayer resistance.
The pH stat method estimates the net acid or base secretion across a monolayer by measuring the amount of acid or base that must be added to the unbuffered apical solution to clamp its pH to 7.4. In our experiments, the unbuffered apical solution always alkalinized to varying degrees, so we added appropriate volumes of 3 mM acid (HCl or HNO 3 in Cl Ϫ -free solutions) manually to keep the apical pH within the range 7.37-7.43. Net base secretion was then converted into an equivalent current (I eq) on the assumption that one net unit of base carried one net negative charge. Figure 2 shows two raw pH traces from a Calu-3 monolayer that had been pretreated with bumetanide, an inhibitor of the Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC). Acid was added near the start of the trace, and the subsequent slow alkalinization of the apical solution (dark line) was taken to reflect a low net level of secretion of base, which was assumed to be HCO 3 Ϫ . Stimulation with 1-EBIO caused the solution to alkalinize more quickly (dotted line), as seen by the increased slope of alkalinization and the increased rate of acid addition. This increase in acid addition rate is seen as an increase in I eq.
For pH stat experiments, there can be no buffer in the apical solution, especially HCO 3 Ϫ . Therefore, we used K-H solution where all salts were Cl Ϫ salts and no buffers were present (NaHCO3 replaced by NaCl). The nominally unbuffered apical solution was further conditioned by bubbling with pure O 2 for ϳ1 h before the experiment to remove traces of CO2 and HCO 3 Ϫ introduced by the mounting of the monolayer. The basolateral solution is standard K-H buffer bubbled with 95% O 2-5% CO2.
The unbuffered apical solution in pH stat experiments creates gradients for HCO 3 Ϫ and CO2 across the monolayer. We have preliminary evidence that the paracellular pathway is equally permeable to Na ϩ and Cl Ϫ and minimally permeable to HCO 3 Ϫ (data not shown), which may explain why we observed little ISC offset in pH stat experiments. By convention, a positive or upward deflection in ISC indicates anion secretion or cation absorption and in this system is known to include both Cl Ϫ and HCO 3 Ϫ secretion and Na ϩ absorption via Na ϩ -glucose cotransport (8, 20, 34) . Amiloride-sensitive Na ϩ current was not observed (32) . We eliminated Na ϩ absorption with apical phlorizin or removal of apical glucose. The percent change produced by inhibitors was corrected for a ouabain-sensitive pump current (usually ϳ5 A/cm 2 ) present at the end of each experiment.
Reagents
The stocks for thapsigargin (applied at 300 nM to both sides of the epithelium to inhibit the endoplasmic reticulum Ca 2ϩ -ATPase and thus elevate [Ca 2ϩ ]i ), acetazolamide (100 M), 4,4Ј-dinitrostilbene-2,2Ј-disulfonic acid (DNDS; 3 mM applied basolaterally to block the Na ϩ -HCO 3 Ϫ cotransporter; Ref. 24) , and ouabain (10 M to block K ϩ -ATPases) were made in water at ϫ1,000 (or ϫ100 for DNDS). The stocks for 1-EBIO (applied at 1 mM to both sides to open Ca 2ϩ -activated K ϩ channels directly; Ref. 8) and bumetanide (ϳ10 M applied basolaterally to block the NKCC) were made in DMSO at ϫ1,000. Forskolin (10 M applied basolaterally to activate adenylate cyclase and hence CFTR) was made at ϫ1,000 in ethanol.
Statistical significance was determined by use of the Student's t-test on Microsoft Excel, with either paired or unpaired tests as appropriate. Figure 3A illustrates the main features of Calu-3 I SC that we are attempting to understand. In the absence of any apparent stimulation, Calu-3 monolayers develop a basal I SC that varies widely in different laboratories and sometimes within laboratories at different times, with mean values in the literature from 13 to 35 A/cm 2 (6, 8, 23) . Mean basal I SC values in our experiments clustered in two groups of 56.3 Ϯ 7.4 A/cm 2 (n ϭ 11, high basal current) and 21.2 Ϯ 2 A/cm 2 (n ϭ 28, low basal current) when tested with phlorizin or zero apical glucose to eliminate the Na ϩ -glucose cotransporter (34) . In cells with high basal I SC , forskolin had a minimal effect (for example, Fig.  3A) , showing on average a 6% increase to 58.2 Ϯ 10.1 A/cm 2 (n ϭ 23), whereas in cells with low basal I SC , forskolin caused a 100% increase in I SC to 43.6 Ϯ 3.8 A/cm 2 (n ϭ 17). Thus forskolin stimulation eliminated the significant difference between the groups for I SC (P Ͼ 0.05), resistance (250 Ϯ 40 for high basal vs. 350 Ϯ 50 ⍀⅐cm 2 for low basal, P Ͼ 0.05), and the proportion of I SC eliminated by bumetanide (20 Ϯ 4% for high basal, n ϭ 14, vs. 12 Ϯ 3% for low basal, n ϭ 10). We Fig. 3 . A: example of ISC recording from Ussing Chamber. The width of the line is a measure of the monolayer conductance; it represents closely spaced deflections to 2-mV pulses given every 10 s. A basal current (range 3-180 A/cm 2 , n ϭ 39) was seen in every experiment. In this example of high basal short-circuit current (ISC), forskolin, which raises intracellular cAMP concentration ([cAMP]i) and opens CFTR channels, caused only a small ISC, as if the monolayer had already been stimulated. Thapsigargin, which raises intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i), caused a rapid rise to a peak. As the ISC began a gradual decline, bumetanide was added basolaterally to block the NKCC, and the current fell rapidly, but the ISC after bumetanide remained larger than it was before thapsigargin, and conductance remained high. The larger ISC is an increase in HCO 3 Ϫ current due to thapsigargin stimulation, because acetazolamide, a blocker of carbonic anhydrase, and basolateral (3 mM) 4,4Ј-dinitrostilbene-2,2Ј-disulfonic acid (DNDS), which blocks the NBC, each reduced the bumetanide-insensitive ISC. B: evidence for large contribution of CO2 conversion to bumetanide-insensitive ISC. All cells were inhibited with bumetanide and stimulated with forskolin and then treated with DNDS, acetazolamide (Acetaz), or 1-EBIO as shown. DNDS was less effective than acetazolamide overall and was less effective after the cell was hyperpolarized by 1-EBIO (*P Ͻ 0.05). The pH of the unbuffered apical NaCl solution is constantly monitored and is held to a narrow range around pH 7.4 by adding small, equal aliquots of acid or base while continuously gassing with O2. In our experiments, the apical solution always became basic so that only acid additions were needed; the rate of acid addition thus reflects the rate of base secretion into the apical solution. The acid neutralizes the secreted base and is converted to an equivalent current, assuming that base is univalent HCO 3 Ϫ . In this example, ϳ1 aliquot of acid was added per 10 min for unstimulated cells (thicker dark line). Stimulation with 1-EBIO led to a marked increase in HCO 3 Ϫ secretion (dotted line) and a 7-fold increase in the rate of acid addition; the equivalent current (Ieq) increased from 4 to 30 A/cm 2 .
RESULTS
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did not determine the source(s) of variation in basal I SC, but these results suggest that Calu-3 cell sheets with high basal I SC resemble those that have been forskolin stimulated, both having an I SC of ϳ50 A/cm 2 . Stimulation with either thapsigargin or 1-EBIO, each of which results in open basolateral K ϩ channels (2, 7), should increase the driving force for anion secretion and produce a proportional increase in I SC . That was observed, with the responses peaking and then falling to a plateau (Fig. 4) . Plateau increases were ϩ177 Ϯ 72% (n ϭ 4) for high basal and ϩ156 Ϯ 61% (n ϭ 7) for low basal (Table 1) , with corresponding decreases in transepithelial resistance (ϳ190 ⍀⅐cm 2 for both high and low basal). Addition of bumetanide just after the peak I SC caused an immediate inhibition of most of the stimulated I SC ( Fig. 3A ; Table 1 ) . However, note in Fig. 3A that the I SC after thapsigargin stimulation and bumetanide inhibition was larger than before stimulation. That was observed consistently; the ⌬I SC to K ϩ channel openers in the presence of bumetanide was 11 Ϯ 3 A/cm 2 for high basal (n ϭ 12) and 12 Ϯ 4 A/cm 2 for low basal (n ϭ 17). It will be shown below that this ⌬I SC represents increased HCO 3 Ϫ secretion. To determine the basis of the bumetanide-insensitive I SC , acetazolamide was added to inhibit carbonic anhydrase, and DNDS was added to inhibit the basolateral NBC. Before 1-EBIO stimulation (but after bumetanide inhibition), DNDS (3 mM) inhibited 12.2 Ϯ 2.5 A/cm 2 of the I SC (high basal, n ϭ 10, Table 1 ), and after 1-EBIO stimulation, DNDS inhibited less of the I SC (7.8 Ϯ 2.2 A/cm 2 , high basal, n ϭ 10). Under the same conditions (high basal cells), acetazolamide inhibited significantly more I SC before than after stimulation (16.2 Ϯ 3.5 A/cm 2 , n ϭ 8, Table 1 , vs. 30.5 Ϯ 2.7 A/cm 2 , P Ͻ 0.05, n ϭ 11).
The contribution of DNDS-and acetazolamide-sensitive transport to the bumetanide-insensitive I SC varied with stimulation (Fig. 3B) . After forskolin, similar proportions of the I SC were inhibited by DNDS (20%) or acetazolamide (27%), but after 1-EBIO, there was a large disparity in the proportion of the I SC inhibited by DNDS (10%) vs. acetazolamide (37%). The DNDS-sensitive component of the I SC decreased after 1-EBIO stimulation (P ϭ 0.03), and the acetazolamide-sensitive component of the I SC increased after 1-EBIO stimulation.
These results suggest four provisional conclusions. -dependent secretion after stimulation is mediated by carbonic anhydrase-generated HCO 3 Ϫ .
3) The contribution of NBC is relatively minor. 4) After 1-EBIO stimulation, NBC is not working in reverse, because if it were DNDS should have increased the I SC .
To determine whether prior treatment with bumetanide influenced the DNDS results, we compared the inhibitory effect of DNDS on the 1-EBIO-stimulated I SC in paired experiments with and without bumetanide (low basal cells). DNDS alone inhibited 14.6 Ϯ 1.0% of 1-EBIO-stimulated I SC , and this was reduced to 9.1 Ϯ 0.5% after bumetanide (n ϭ 10, P Ͻ 0.001, Fig. 3B ). The significant reduction in DNDS inhibition after bumetanide inhibition of NKCC might arise if the diminished intracellular Cl Ϫ results in hyperpolarization of the cells, which would then reduce the transport of HCO 3 Ϫ by the NBC (see DISCUSSION) .
A substantial I SC (32% of forskolin-stimulated I SC , Table 1 ) remained after combined treatment with bumetanide, DNDS, and acetazolamide. Evidence to be presented below suggests that this I SC includes a component of HCO 3 Ϫ secretion derived from the uncatalyzed conversion of CO 2 ϩ H 2 O to HCO 3 Ϫ , which still proceeds relatively rapidly in the absence of carbonic anhydrase, with a half-time of ϳ5 s (12).
Analysis of I SC with pH Stat Experiments
Measurement of I SC under pH stat conditions is designed to maximize ionic currents while providing an additional measure of acid/base movement, and no other method can provide the same kind of information. However, pH stat results have been questioned because the technique creates an artificially large HCO 3 Ϫ gradient across the cells and across the paracellular space. If any of the drugs caused a changed in the paracellular pathway's HCO 3 Ϫ conductance, this might lead to a noncellular response. To estimate the magnitude of any artifact that might have arisen from the HCO 3 Ϫ gradient, we measured the I SC in paired Ussing (apical and basolateral solutions clamped to 25 mM HCO 3 Ϫ ) and pH stat experiments (zero apical HCO 3 Ϫ ). Any change of HCO 3 Ϫ movement across the paracellular pathway will pro- 
Neither of these measures showed a significant increase in HCO 3 Ϫ secretion during the pH stat method; in fact, the trend was toward a smaller I SC when the apical solution lacked HCO 3 Ϫ . This independence from the HCO 3 Ϫ gradient can be explained if there is minimal movement of HCO 3 Ϫ across the tight junctions, and if the limiting factor for HCO 3 Ϫ I SC is not dependent on either the apical HCO 3 Ϫ conductance or on gradient-sensitive mechanisms for HCO 3 Ϫ accumulation (e.g., NBC). Instead, the rate-limiting step in maximally stimulated cells appears to be the gradient-insensitive and voltage-insensitive production of HCO 3 Ϫ from CO 2 . The CO 2 inside the Calu-3 cells in pH stat experiments is likely to be Ͻ5%, because the basolateral CO 2 is 5% and the apical CO 2 is 0%. Because CO 2 and HCO 3 Ϫ are in equilibrium inside the cell (assuming constant intracellular pH), the lower CO 2 level leads to a lower HCO 3 Ϫ level and less HCO 3 Ϫ current. The power of the pH stat technique is that it provides an estimate of the net base (HCO 3 Ϫ ) movement across the monolayer. The assumption underlying these experiments was that Calu-3 cell I SC is the sum of NKCC-mediated Cl Ϫ secretion plus HCO 3 Ϫ secretion, but it quickly became apparent that the assumption was not valid. Instead, an unidentified process was producing a discrepancy between I SC and I eq measurements.
Forskolin-stimulated monolayers in the pH stat experiments had an I SC of 65 Ϯ 5 A/cm 2 (n ϭ 15, high basal) or 44 Ϯ 2 A/cm 2 (n ϭ 15, low basal), and the I eq was approximately two-thirds of the I SC in both high and low basal conditions (Figs. 4 and 5) . Bumetanide blocked 18 Ϯ 3% (n ϭ 11) of the I SC and none of the I eq , leaving 13% of the forskolin-stimulated I SC unexplained (Fig. 5) . Stimulation with 1-EBIO after forskolin produced a further large increase in I SC (110 Ϯ 21%, n ϭ 6), but, surprisingly, the I eq remained stable (increase of 2.5 Ϯ 5%, n ϭ 6, Fig. 4) . We had expected an increase in I eq on the basis of the evidence just presented that 1-EBIO increased the bumetanide-insensitive and acetazolamide-sensitive I SC , consistent with increased driving force on carbonic anhydraseproduced HCO 3 Ϫ . On the other hand, if HCO 3 Ϫ secretion depended entirely on an NBC with 2:1 stoichiometry, it should have been eliminated under these conditions (8) . Neither expectation was met.
Furthermore, in the presence of bumetanide, 1-EBIO produced a significant increase in I SC but not in I eq . This is shown most strikingly in Fig. 5 , where, in the presence of bumetanide, 1-EBIO stimulates a 20 A/cm 2 increase in I SC but a slight decrease in I eq . On average, in the presence of bumetanide 1-EBIO increased the I SC by 27 Ϯ 9% (n ϭ 13) and the I eq by 11 Ϯ 7% (n ϭ 9, not significantly different from 0), further increasing the discrepancy between I SC and I eq so that I eq was on average only 70 Ϯ 4% of I SC (n ϭ 9, Figs. 4 
and 5).
Bovine tracheal epithelial cells (28), Calu-3 cells (14), and cultured human bronchial epithelium (4) each express H ϩ -K ϩ -ATPase, and, at least in the human cells, expression in the apical membrane is only of the nongastric form. These results suggest the possibility that some of the HCO 3 Ϫ -based I eq was being neutralized by K ϩ -dependent H ϩ secretion. To test this idea, ouabain (10 -20 M), a nonspecific H ϩ -K ϩ -ATPase inhibitor, was added apically after 1-EBIO stimulation and bumetanide inhibition (Fig. 5) . Apical ouabain had no effect on the I SC (n ϭ 9), showing that it did not have access to the basolateral bath but instead caused a dramatic increase in I eq from 70 Ϯ 4 to 95 Ϯ 1% of the I SC (n ϭ 9, P Ͻ 0.0001, paired; see Figs. 5 and 6B).
As an additional test of a role for a putative H ϩ -K ϩ -ATPase, we omitted K ϩ from the apical solution. With a nominally K ϩ -free apical solution, the I eq and the I SC after 1-EBIO in the presence of bumetanide were equivalent (94 Ϯ 4%, n ϭ 6, P Ͻ 0.0001 vs. control), and apical ouabain had no further effect on I eq (n ϭ 6, Fig. 6A) . Similarly, when cells were stimulated with 1-EBIO in the presence of apical ouabain and bumetanide, the I SC and I eq rose together, and I eq was 100 Ϯ 4% of I SC (n ϭ 9, P Ͻ 0.001 vs. control, Fig. 6B ). These results indicate that a ouabain-sensitive, K ϩ -dependent nonelectrogenic process of acid secretion is stimulated in Calu-3 cells by 1-EBIO in parallel with increased Cl Ϫ and HCO 3 Ϫ secretion. One possible mechanism for such secretion is the nongastric form of H ϩ -K ϩ -ATPase, which others have shown to be expressed in Calu-3 cells (14, 28) .
To determine whether ouabain-sensitive H ϩ secretion was also stimulated by forskolin, ouabain was added apically during forskolin-stimulated I SC but before 1-EBIO addition. Ouabain did not alter either I SC or I eq in forskolin-stimulated cells (n ϭ 9, Fig. 6B ), suggesting that H ϩ -K ϩ -ATPase is not activated by forskolin stimulation. Ϫ secretion and its masking by H ϩ secretion via H ϩ -K ϩ -ATPase. As in Fig. 4 , the top trace is ISC and the bottom trace is computed Ieq. The monolayer was prestimulated with 10 M forskolin. The Cl Ϫ component of the ISC was inhibited with bumetanide but remained larger than the Ieq. Stimulation with 1-EBIO in the presence of bumetanide increased the ISC by ϳ50%, but there was little change in Ieq. The large gap between ISC and Ieq induced by 1-EBIO is caused by concomitant stimulation of H ϩ secretion, as shown by the effect of apical ouabain (10 -20 M), which inhibits H ϩ -K ϩ -ATPase and caused the Ieq to increase until Ieq ϭ ISC. Thus all ISC after bumetanide could be accounted for by HCO 3 Ϫ secretion, which was increased by 1-EBIO and unmasked (in terms of Ieq) by apical ouabain. Subsequent addition of acetazolamide caused a large and equivalent inhibition of both ISC and Ieq. The remaining secretion of HCO 3 Ϫ is proposed to represent the uncatalyzed formation of HCO 3 Ϫ from CO2 (see text).
Ussing Chamber Experiments in HCO 3 Ϫ -Free Media (Cl Ϫ as the Only Permeant Anion)
The results so far indicate that HCO 3 Ϫ is secreted by Calu-3 cells under all of the conditions we tested and is derived to a large extent from conversion of CO 2 to HCO 3 Ϫ , because I SC is inhibited by acetazolamide. However, acetazolamide might have other effects including inhibition of NKCC. To study the NKCC transporter in relative isolation, we performed Ussing chamber experiments on Calu-3 cells in HEPES-buffered HCO 3 Ϫ -free media, where Cl Ϫ is the only CFTR-permeant anion (Table 2) . Figure 7 shows a typical experiment under these conditions. In unstimulated (high basal) or forskolin-prestimulated cells, the initial I SC was 45 Ϯ 4 A/cm 2 if glucose was present in the apical solution and was decreased to 35 Ϯ 5 A/cm 2 by addition of phlorizin (Table 2 ). 1-EBIO caused a large sustained increase in I SC of 64 Ϯ 4 A/cm 2 (n ϭ 4) ( Fig. 7 and Table 2 ). Thapsigargin increased the I SC by 35 Ϯ 4 A/cm 2 (n ϭ 5). Bumetanide inhibited ϳ90% of the unstimulated I SC (n ϭ 12, Table 2 ) and 100% of the I SC stimulated by either 1-EBIO or thapsigargin (n ϭ 7). Thus NKCC is the major pathway for transporting Cl Ϫ into the cell under all the conditions we tested.
Acetazolamide and DNDS had negligible effects on I SC ( Fig.  7 and Table 2 ). The lack of inhibition by these agents is an important result because it indicates that their ability to inhibit I SC when HCO 3 Ϫ is present (34) (Fig. 2 and Table 1) is not a nonspecific effect. This further supports a role for CO 2 conversion as well as basolateral HCO 3 Ϫ uptake in HCO 3 Ϫ secretion (20) .
The I SC properties of Calu-3 cells when Cl Ϫ is the only CFTR-permeant anion resemble the properties of T84 cells in normal media, where inhibition of NKCC with bumetanide eliminates essentially all I SC , as reported in a long series of experiments by Dharmsathaphorn et al. (9) and others (3).
I SC in Cl Ϫ -Free Solutions (HCO 3 Ϫ is the Only Permeant Anion)
In these experiments, we attempted to isolate the pathways responsible for HCO 3 Ϫ secretion and further assess the relative contributions of CO 2 conversion and Na ϩ -HCO 3 Ϫ cotransport. When all Cl Ϫ in the bathing solutions was replaced with isethionate, leaving 25 mM HCO 3 Ϫ as the only CFTR-permeant The bar graph shows Ieq as a percentage of ISC in monolayers pretreated with bumetanide and then stimulated with 1-EBIO or thapsigargin, either in control conditions (normal pH stat apical fluid, n ϭ 9) or in conditions in which the putative H ϩ -K ϩ -ATPase was disabled either with apical ouabain (10 -20 M) added initially (prestim; n ϭ 9) or after 1-EBIO (poststim; n ϭ 9) or K ϩ -free apical fluid (n ϭ 6). Each condition is significantly different from control (P Ͻ 0.001). anion, a high basal current of 43 Ϯ 3 A/cm 2 remained ( Fig.  8 and Table 3 ). Apical phlorizin inhibited ϳ25% of this basal I SC , indicating that the electrogenic Na ϩ -glucose cotransporter was highly active under these conditions (Table 3) . A possible reason for the increased activity of Na ϩ -glucose cotransport is that the driving force for Na ϩ entry is increased because the cells are hyperpolarized, and intracellular Na ] i gradient will dominate the membrane potential and move it toward the K ϩ reversal potential (E K ). However, evidence that the cells are still far from E K is provided by the response to thapsigargin or 1-EBIO. These agents stimulated increases in I SC of 107% (n ϭ 4) and 163% (n ϭ 5), respectively, and corresponding large increases in transepithelial conductance, indicating that, although the membrane potential may have been hyperpolarized by removal of Cl Ϫ , it was still depolarized relative to E K before stimulation ( Fig. 8 and Table 3 ).
With HCO 3 Ϫ as the only CFTR-permeant anion, bumetanide was without effect, as expected (Fig. 8, Table 3 ), whereas acetazolamide inhibited 26 Ϯ 3% of the basal I SC (n ϭ 9), and DNDS inhibited 25 Ϯ 4% (n ϭ 9, Table 3 ). After stimulation with 1-EBIO, the acetazolamide inhibition increased to 45 Ϯ 6% (significant increase, P ϭ 0.005), and the DNDS inhibition decreased to 11 Ϯ 8% (decrease not significant). The substantial I SC that remained after inhibition with bumetanide, acetazolamide, and DNDS (30 Ϯ 6%, n ϭ 6) of stimulated I SC could represent Na ϩ absorption via unknown pathways or continued secretion of HCO 3 Ϫ from unknown sources. To decide among these possibilities, glibenclamide and N-phenylanthranilic acid (DPAC), which are frequently used to inhibit CFTR (but have other actions), were tested for their ability to inhibit I SC in Cl Ϫ -free media. Each produced nearly complete inhibition of I SC and increased the monolayer resistance (n ϭ 8), implying that all the I SC was current through CFTR.
The results in zero Cl Ϫ make three points. 1) Because DNDS inhibited the I SC , the NBC was still causing an influx of HCO 3 Ϫ under these conditions. This could be because [Na ϩ ] i was reduced secondary to NKCC inactivity, but the magnitude of DNDS inhibition did not differ from that observed in K-H solution.
2) The large effect of acetazolamide emphasizes the importance of CO 2 conversion in HCO 3 Ϫ secretion.
3) The substantial I SC that remains after both pathways for generating intracellular HCO 3 Ϫ concentration are inhibited probably represents continued secretion of HCO 3 Ϫ produced by the uncatalyzed conversion of CO 2 to HCO 3 Ϫ , rather than Na ϩ absorption, because the residual I SC was blocked by glibenclamide and DPAC.
Evidence for a Single Exit Pathway for HCO 3
Ϫ and Cl Ϫ CFTR conducts both Cl Ϫ and HCO 3 Ϫ (15, 21), and glibenclamide blocks I SC carried by either ion (30, 33) . Although glibenclamide is not specific for CFTR (e.g., see Refs. 1, 22), its effect on CFTR might be sufficient to test the hypothesis that both Cl Ϫ and HCO 3 Ϫ exit Calu-3 cells via CFTR. Glibenclamide blocked the I SC with identical dose-inhibition curves (IC 50 of 120 M) in K-H solution or when Cl Ϫ or HCO 3 Ϫ was the only permeant anion (Fig. 9) . The conductance dose- Fig. 9 . Evidence that Cl Ϫ and HCO 3 Ϫ both exit via the same pathway (CFTR). Dose-response curves for glibenclamide inhibition of ISC and transepithelial conductance were the same regardless of the anion that carried the current. The IC50 for each curve was ϳ120 M with a Hill slope of ϳ1, implying that only one glibenclamide molecule is needed to block CFTR. The inhibition of conductance (■, in K-H solution) mirrored that of the ISC (ᮀ) inhibition in K-H solution conditions, suggesting that the common anion secretion pathway is electrogenic (like a channel) and not electroneutral. Ϫ as the only permeant anion (zero Cl Ϫ , replaced with isethionate). In the basal or forskolin-stimulated state, the ISC is carried by HCO 3 Ϫ , and 1-EBIO causes an increase in HCO 3 Ϫ secretion. Bumetanide (10 M basolateral) had no effect on the ISC, as expected for a pure HCO 3 Ϫ current. Acetazolamide (100 M apical ϩ basolateral) eliminated ϳ1/2 of the total ISC seen after stimulation. DNDS (3 mM basolateral) had an additional small inhibitory effect, implying that the NBC was not reversed by 1-EBIO stimulation. The slight increase in ISC seen before bumetanide addition was caused by restoration of bubbling in the Ussing chamber, which had briefly stopped by accident. 
Estimation of HCO 3
Ϫ /Cl Ϫ Conductance
Direct comparisons of the I SC in Cl Ϫ -only and HCO 3 Ϫ solutions cannot be made because the driving forces in each condition are not known. However, a comparison is possible if we make the simplifying assumption that, at the peak of the 1-EBIO response, the cell voltage goes to E K . In HCO 3 Ϫ -only solutions, the initial cell voltage is determine by the HCO 3 Ϫ reversal potential (E B ), the HCO 3 Ϫ conductance (G B ), the E K , and the initial K ϩ conductance (G K ). The fold increase in the driving force after 1-EBIO stimulation is proportional to (G B )/ (G K ). Thus the ratio of the peak fold increase stimulated by 1-EBIO in HCO 3 Ϫ -only solutions and Cl Ϫ -only solutions should reflect the HCO 3 Ϫ -to-Cl Ϫ permeability ratio (Fig. 10, A  and B) .
The peak fold increase in the HCO 3 Ϫ -only solution was 2 (Fig. 10C, open bar ) vs. a peak fold increase of 7 in the Cl Ϫ -only solution (Fig. 10C, solid bar) . [The peak fold increase in K-H solution that contains both HCO 3 Ϫ and Cl Ϫ current was intermediate (Fig. 10C , gray bar), consistent with 1-EBIO stimulation causing both Cl Ϫ and HCO 3 Ϫ efflux through CFTR.] The ratio of the fold increases was 2/7, giving a HCO 3 Ϫ conductance that is 29% of the Cl Ϫ conductance, a value similar to estimates for CFTR arrived at by other methods (15, 21, 27) . It is possible that the cell voltage does not actually reach E K because of the apical anion conductance through CFTR, and this effect will be greatest in Cl Ϫ -only solutions. 
Evaluation of Model 1
We began these studies to examine perceived inconsistencies between model 1 (Fig. 1) and results from experiments in our laboratory. We considered three features of the model. 1) Is most HCO 3 Ϫ derived from the activity of an NBC? 2) Does the NBC have a stoichiometry that causes it to be reversed by cellular hyperpolarization, i.e., does it export HCO 3 Ϫ basolaterally after stimulation? 3) As predicted by these features of the model, does activation of basolateral K ϩ channels with 1-EBIO cause Calu-3 cells to secrete a highly acidic fluid, essentially devoid of HCO 3 Ϫ , with Cl Ϫ as the only anion (8)? Our results lead us to answer "no" to all three questions. Feature 1. We found that most HCO 3 Ϫ was not derived from NBC-mediated transport but is instead generated by a carbonic anhydrase-dependent mechanism. In our experiments, the DNDS-sensitive pathway contributed ϳ20% of forskolin-stimulated HCO 3 Ϫ secretion and ϳ10% of 1-EBIO-stimulated HCO 3 Ϫ secretion (Fig 3B) . Most of the HCO 3 Ϫ current was acetazolamide sensitive, suggesting that conversion of CO 2 to HCO 3 Ϫ is the predominant mechanism for generating intracellular HCO 3 Ϫ concentration (Fig. 3B ). An acetazolamide-insensitive, DNDS-insensitive source for HCO 3 Ϫ was also found, which could represent uncatalyzed conversion of CO 2 to HCO 3 Ϫ , a reaction that proceeds rapidly with a half-time of only ϳ5 s (12) . The unidentified source for HCO 3 Ϫ may also include a contribution from anion exchanger-2, which exists in the basolateral membrane of Calu-3 cells (23) . Because none of these pathways are voltage sensitive, they are well suited to mediating HCO 3 Ϫ transport in hyperpolarized cells. Feature 2. We found that the NBC was not reversed by cellular hyperpolarization, because DNDS continued to inhibit I SC after 1-EBIO stimulation. DNDS inhibition was significantly less after 1-EBIO. These results are consistent with recent experiments on two different NBC [rkNBC (31) and NBC4 (35) ] that found that both transport HCO 3 Ϫ 2:1 over Ϫ in forskolin-stimulated and 1-EBIO-stimulated conditions. If we assume that 1) the potassium conductance is identical whether Cl Ϫ or HCO 3 Ϫ is the permeant anion, 2) the voltage developed upon 1-EBIO stimulation equals EK, and 3) the anion concentration does not change significantly in the short time it takes the response to peak, then the ISC is determined by the driving force (arrows) and the ratio of peak ISC to forskolin-stimulated ISC is proportional to the ratio of the anion conductance to the K ϩ conductance. B: as in A except showing conditions when Cl Ϫ is the only CFTR-permeant anion. C: mean peak fold increases in ISC induced by 1-EBIO for HCO 3 Ϫ (n ϭ 8), Cl Ϫ (n ϭ 6), and Krebs (n ϭ 6). The fold increases in HCO 3 Ϫ are smaller than Cl Ϫ , and the amplitudes imply that the HCO 3 Ϫ conductance is at most 29% of the Cl Ϫ conductance. (6), and theoretical considerations suggest that optimal secretion requires 10 -20% of the K ϩ conductance to be apical (5) . We have shown that when K ϩ is present in the apical solution, it is exchanged for H ϩ , and, under the conditions of our pH stat experiments, it neutralizes part of the HCO 3 Ϫ . In summary, our present results for hyperpolarized Calu-3 cells supply a mechanism to reconcile the increased HCO 3 Ϫ secretion measured by Lee et al. (20) with the lack of HCO 3 Ϫ secretion proposed by Devor et al. (8) . As shown in Figs. 5-6, stimulation with 1-EBIO or thapsigargin in the presence of bumetanide increases I SC by increasing both HCO 3 Ϫ secretion and H ϩ secretion. H ϩ secretion was blocked either with apical ouabain or elimination of apical K ϩ , suggesting that H ϩ -K ϩ -ATPase is responsible. An apical H ϩ -K ϩ -ATPase has been reported in Calu-3 cells (14) and in human surface airway epithelium (4). In the human airway, the activity of H ϩ -K ϩ -ATPase does not appear to be regulated (4) . Furthermore, its sensitivity to ouabain (500 M was used) may be less than we observed; the inhibitory curve for the nongastric H ϩ -K ϩ -ATPase protein expressed from ATP1AL1/␤ H-K (25) can accommodate both our observations and those in surface airway epithelium. Thus the ouabain-sensitive mechanism described here could also be a variant nongastric H ϩ -K ϩ -ATPase or yet another K ϩ -dependent mechanism.
Role of CFTR
Model 1 proposes that both Cl Ϫ and HCO 3 Ϫ are conducted through CFTR, with no provision made for apical anion exchangers. Our results strongly support that aspect of model 1: either both anions are conducted through CFTR, or their secretion is mediated by a transporter that is completely dependent on CFTR. We show two CFTR channels in Fig. 1 for clarity and also because of evidence that Cl Ϫ and HCO 3 Ϫ conductances mediated by CFTR can be independently controlled (29) .
Implications for Airway Submucosal Gland Mucus Secretion
The gland serous cells that are modeled by Calu-3 cells contribute ϳ50% of the secretory apparatus of glands, with the other 50% consisting of mucous cells that do not express CFTR. Secretions from both types of cells pass through a ductal system comprising at least two cell types, which presumably modifies the secretions in as-yet-unknown ways. We noted in the introduction that predictions from model 1 do not fit with observations of secretions from actual glands, which invariably have less than one-half as much HCO 3 Ϫ as the bath (mucus pH ϳ7.0 vs. bath pH of 7.4) under all stimulation conditions, across species and in both CF and control subjects (16, 18) . As a further paradox, secretions from human airway glands are hypotonic (16, 19) . To explain these results, we originally hypothesized that cells in the gland (mucous cells?) secrete HCO 3 Ϫ via a non-CFTR-dependent pathway and that secondary processes in the gland modified the secretions homeostatically so that the pH of the final secretion is adjusted to near pH 7, regardless of the starting secretion. We had no explanation for how gland secretions might become hypotonic.
A New Role for HCO 3 Ϫ : the Ion Subtraction Hypothesis
The discovery of a regulated apical pathway for H ϩ secretion (H ϩ -K ϩ -ATPase) provides one possible mechanism for adjusting the pH of the submucosal gland secretions. Furthermore, concordant H ϩ and HCO 3 Ϫ secretion provides a potential explanation for 1) pH regulation, 2) hypotonicity of gland secretions, and 3) the discordance between expected high levels of HCO 3 Ϫ secretion from gland serous cells and the observation that the final secretions from glands are essentially neutral. Unlike in the large volumes of an Ussing chamber, the secretions of gland cells completely determine the composition of their luminal fluid. The importance of controlling pH and osmolarity is likely to be crucial given the abundant quantities of diverse macromolecules that are also secreted by the gland cells. If the two-step conversion of K ϩ -HCO 3 Ϫ to H ϩ -HCO 3 Ϫ and then to CO 2 ϩ H 2 O that has been demonstrated here can be shown to apply to intact glands, it will provide a new control mechanism for both the tonicity and pH of airway surface liquid. It is apparent that this mechanism also alters the expected consequences of lost CFTR function.
